Lys05
CAS No. 1391426-24-6
Lys05 ( Lys-05 | Lys 05 | Lys01 trihydrochloride | PS-1001 )
产品货号. M11622 CAS No. 1391426-24-6
Lys05(Lys01三盐酸盐,PS-1001)是Lys01的水溶性盐,是一种比羟氯喹(HCQ)强10倍的溶酶体自噬抑制剂;在MTT测定中显示1205Lu、c8161、LN229和HT-29细胞系的IC50值为3.6、3.8、6和7.9 uM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥389 | 有现货 |
|
| 5MG | ¥648 | 有现货 |
|
| 10MG | ¥988 | 有现货 |
|
| 25MG | ¥1798 | 有现货 |
|
| 50MG | ¥3013 | 有现货 |
|
| 100MG | ¥4358 | 有现货 |
|
| 500MG | ¥9315 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Lys05
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Lys05(Lys01三盐酸盐,PS-1001)是Lys01的水溶性盐,是一种比羟氯喹(HCQ)强10倍的溶酶体自噬抑制剂;在MTT测定中显示1205Lu、c8161、LN229和HT-29细胞系的IC50值为3.6、3.8、6和7.9 uM。
-
产品描述Lys05 (Lys01 trihydrochloride, PS-1001)?is the water-soluble salt of Lys01, is a 10-fold more potent lysosomal autophagy inhibitor than hydroxychloroquine (HCQ); shows IC50 values of 3.6, 3.8, 6 and 7.9 uM for 1205Lu, c8161, LN229 and HT-29 cell line in the MTT assay;?more potently accumulates within and deacidifies the lysosome, resulting in impaired autophagy and tumor growth; enhances sunitinib-mediated suppression of clear cell ovarian carcinoma (CCOC) cell viability.
-
体外实验Lys01, is a 10-fold more potent autophagy inhibitor than HCQ. Compared with HCQ, Lys05, a water-soluble salt of Lys01, more potently accumulates within and deacidifies the lysosome. Lys01 and Lys05 produce equivalent dose-dependent increases in the LC3II/LC3I ratio, accumulation of the autophagy cargo protein p62, and identical IC50 values in the MTT assay.
-
体内实验With this high-dose, short-term treatment, no mice die, but after 2 d of dosing, mice treated with Lys05 76 mg/kg i.p. are observed to have arched backs and lethargy. Morphologically, EM show that cells with intact nuclear and cytoplasmic membranes contain large AVs in Lys05-treated tumors. Tumor growth is significantly impaired in Lys05-treated tumors compared with controls. Lys05 treatment results in a 53% reduction in the average daily tumor growth rate compared with vehicle-treated controls. A significant three- and six-fold accumulation of AV is observed at the end of 14 d of treatment in HCQ- and Lys05-treated tumors, respectively, compared with control-treated tumors.
-
同义词Lys-05 | Lys 05 | Lys01 trihydrochloride | PS-1001
-
通路Autophagy
-
靶点Autophagy
-
受体lysosomalautophagy(1205Lu)|lysosomalautophagy(c8161)|lysosomalautophagy(HT-29)|lysosomalautophagy(LN229)
-
研究领域——
-
适应症——
化学信息
-
CAS Number1391426-24-6
-
分子量549.75
-
分子式C23H26Cl5N5
-
纯度>98% (HPLC)
-
溶解度DMSO: 6.4 mg/mL, Need Ultrasonic; Water: 3 mg/mL (5.5 mM); Ethanol: <1 mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESCN(CCNC1=CC=NC2=CC(Cl)=CC=C12)CCNC3=CC=NC4=CC(Cl)=CC=C34.[H]Cl.[H]Cl.[H]Cl
-
化学全称N2-(7-Chloro-4-quinolinyl)-N1-[2-[(7-chloro-4-quinolinyl)amino]ethyl]-N1-methyl-1,2-ethanediamine trihydrochloride
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. McAfee Q, et al. Proc Natl Acad Sci U S A. 2012 May 22;109(21):8253-8.
2. Amaravadi RK, et al. Autophagy. 2012 Sep;8(9):1383-4.
3. DeVorkin L, et al. Mol Cancer Res. 2017 Mar;15(3):250-258.
4. Ndoye A, et al. Cancer Res. 2017 Nov 1;77(21):5873-5885.
产品手册
关联产品
-
ARN-5187
一种新型溶酶体 REV-ERB 配体,对 REV-ERB 介导的转录调节和自噬具有双重抑制活性。
-
Sulfapyridine
Sulfapyridine(Dagenan) 是一种磺酰胺类抗菌剂。
-
Sulfisoxazole
磺胺异恶唑是一种内皮素受体拮抗剂,是一种带有恶唑取代基的磺酰胺类抗菌化合物。
021-51111890
购物车()
sales@molnova.cn

